Top 10 Players in the Vietnam Diclofenac Sodium Market | Top Companies & Insights 2026

Vietnam Diclofenac Sodium Market Overview

According to 6Wresearch, the Diclofenac Sodium market in Vietnam is witnessing steady growth, owing to the rising geriatric population and high prevalence of musculoskeletal disorders and osteoarthritis. Diclofenac Sodium is a potent NSAID that is used to control pain, swelling and joint stiffness.

The market is driven by the need for delivery formats in various forms, including oral tablets, topical gels and injectable solutions. Moreover, the government’s rigorous quality control standards and the growing social health insurance system have increased access to these important pain management therapies for the general public.

Competitive Landscape

The Vietnam Diclofenac Sodium industry is highly competitive with several local and international players dominating the market with cost effective generic formulations and specialized delivery systems, including extended-release tablets and topical patches. To maintain their dominant lead, these brands are investing in R&D to improve their pain management portfolios and minimize the side effects.

Below is a list of leading players operating in the Vietnam Diclofenac Sodium Market:

1. DHG Pharmaceutical Joint Stock Company (DHG Pharma)

DHG Pharma is the largest pharmaceutical company, offering a wide range of NSAID formulations through an extensive nationwide distribution network.

2. Traphaco Joint Stock Company

Traphaco is a leading provider of affordable, high-quality generic diclofenac sodium tablets, making essential pain relief accessible.

3. Imexpharm Pharmaceutical Joint Stock Company

Imexpharm produces reliable generic diclofenac products and is a staple in healthcare for over-the-counter and ethical medicines.

4. Domesco Medical Import Export Joint Stock Corporation

Domesco is recognized for its advanced therapeutic offerings and strong presence in the anti-inflammatory drug segment.

5. Bidiphar (Binh Dinh Pharmaceutical and Medical Equipment JSC)

Bidiphar is a leader in the domestic parenteral market, providing specialized injectable diclofenac solutions for clinical and hospital use.

6. Pymepharco Joint Stock Company

Pymepharco specializes in high-quality pharmaceutical manufacturing, including enteric-coated and sustained-release diclofenac formulations.

7. Mekophar Chemical Pharmaceutical Joint Stock Company

Mekophar maintains a dominant force in producing essential ethical drugs for musculoskeletal care.

8. Ha Tay Pharmaceutical Joint Stock Company (Hataphar)

Hataphar focuses on contract manufacturing for global brands, providing robust manufacturing facilities for various anti-inflammatory drug formats.

9. Vinh Phuc Pharmaceutical Joint Stock Company (Vinphaco)

Vinphaco is highly regarded for its wide distribution of affordable analgesics and its commitment to household health brands across the archipelago.

10. Sanofi Vietnam

Sanofi maintains a strong presence through its expertise in developing specialized treatments for chronic inflammatory and musculoskeletal pain.